SCHEMBL3883153

SCHEMBL3883153

OOc1cccc2cc3ccccc3cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 5/20 0.50
GAA P10253 2/20 0.50
NQO1 P15559 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 4/20 0.40
HPGD P15428 4/20 0.40
HIF1A Q16665 1/20 0.39
CYP1B1 Q16678 1/20 0.39
CYP1A2 P05177 3/20 0.38
GLA P06280 1/20 0.38
CYP2C19 P33261 1/20 0.38
CTNNB1 P35222 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
SIRT3 Q9NTG7 1/20 0.36
ERBB2 P04626 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27517857 0.94 ALDH1A1 (0.46) ALDH1A1KDM4EGAANQO1MEN1
SCHEMBL3464859 0.83 GAA (0.46) ALDH1A1KDM4EGAANQO1MEN1
SCHEMBL6338096 0.82 NQO1 (0.46) ALDH1A1KDM4EGAANQO1MEN1
SCHEMBL1783813 0.82 NQO1 (0.46) ALDH1A1KDM4EGAANQO1MEN1
SCHEMBL445495 0.81 CTNNB1 (0.44) ALDH1A1KDM4EGAANQO1MEN1
SCHEMBL31474285 0.80 NQO1 (0.45) ALDH1A1KDM4EGAANQO1MEN1
SCHEMBL9616917 0.80 NQO1 (0.45) ALDH1A1KDM4EGAANQO1MEN1
Lithium SCHEMBL6571294 0.80 NQO1 (0.45) ALDH1A1KDM4EGAANQO1MEN1
SCHEMBL31681883 0.79 ALDH1A1 (0.52) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL3632375 0.79 ALDH1A1 (0.52) ALDH1A1KDM4EGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1300428-B1 (Meth) acrylic crosslinked fine particles and method of manufacturing the same NIPPON CATALYTIC CHEM IND (JP) 2009-01-14 EP claimed
EP-1300428-A2 (Meth) acrylic crosslinked fine particles and method of manufacturing the same Nippon Shokubai Co., Ltd. (JP) 2003-04-09 EP claimed
US-20030064237-A1 (Meth)acrylic crosslinked fine particles and method of manufacturing the same NIPPON SHOKUBAI CO., LTD. (JP) 2003-04-03 US claimed
US-4533766-A Process for the production of dihydroxybenzenes DEGUSSA AKTIENGESELLSCHAFT (DE) 1985-08-06 US claimed
US-20160251289-A1 USE OF ALKANE SULFONIC ACID FOR PREPARING PHENOLIC ALCOHOL ARKEMA FRANCE (FR) 2016-09-01 US disclosed
CN-102015827-B Polycarbonate resin having ultraviolet absorbing capability, resin composition and optical material MITSUBISHI GAS CHEMICAL CO 2012-09-05 CN disclosed
CN-102015827-A Polycarbonate resin having ultraviolet absorbing capability, resin composition and optical material MITSUBISHI GAS CHEMICAL CO 2011-04-13 CN disclosed
EP-1300428-B1 (Meth) acrylic crosslinked fine particles and method of manufacturing the same NIPPON CATALYTIC CHEM IND (JP) 2009-01-14 EP disclosed
US-7056965-B2 Polyoxymethylene resin composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2006-06-06 US disclosed
EP-1300428-A2 (Meth) acrylic crosslinked fine particles and method of manufacturing the same Nippon Shokubai Co., Ltd. (JP) 2003-04-09 EP disclosed
US-20030064237-A1 (Meth)acrylic crosslinked fine particles and method of manufacturing the same NIPPON SHOKUBAI CO., LTD. (JP) 2003-04-03 US disclosed
US-20020183430-A1 Polyoxymethylene resin composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2002-12-05 US disclosed
US-5789506-A Resinous particles, method for production thereof, and uses therefor NIPPON SHOKUBAI CO., LTD. (JP) 1998-08-04 US disclosed
US-5420218-A Suspension polymerization of methacrylates in the presence of acids or alcohols NIPPON SHOKUBAI CO., LTD. (JP) 1995-05-30 US disclosed
EP-0575143-A2 Resinous particles, method for production thereof, and uses therefor NIPPON SHOKUBAI CO., LTD. (JP) 1993-12-22 EP disclosed
US-3979320-A Liquid crystal composition HODOGAYA CHEMICAL CO., LTD. (JA) 1976-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160251289-A1 USE OF ALKANE SULFONIC ACID FOR PREPARING PHENOLIC ALCOHOL ADH1C, ADH1A, ADH5 ALDH1A1 7/4885KDM4E 1543/4885GAA 2056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.